William Bugbee, MD
Adult Reconstructive Orthopaedic Surgery · la Jolla, CANPI 1780642884
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (46.8%), other and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Encore Medical, LP at 30.0% of the total. Among adult reconstructive orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $6183.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$619K
- Orthalign Inc$432K
- Joint Restoration Foundation, Inc.$357K
- Smith+Nephew$287K
- Depuy Synthes Products, Inc.$246K
- Medical Device Business Services, Inc.$49K
- plus $75K from 14 others
Across 8 payments — averaging $3395.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$27K
Across 8 payments — averaging $7523.82 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$33K
- Orthalign Inc$28K
- Insight Medical Systems, Inc.$0
What the payments were for
- Royalty or licence$967,33547%
- Consulting fees$391,51119%
- Speaking & faculty fees$162,1488%
- Travel & lodging$24,4211%
- Food & beverage$5,2080%
- Entertainment$190%
- Other$514,77925%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 88 | $618,698 |
| Orthalign Inc | 28 | $432,318 |
| Joint Restoration Foundation, Inc. | 59 | $357,490 |
| Smith+Nephew | 49 | $286,625 |
| Depuy Synthes Products, Inc. | 18 | $245,950 |
| Medical Device Business Services, Inc. | 27 | $49,271 |
| Arthrex | 24 | $43,280 |
| Moximed, Inc | 3 | $16,200 |
| Bioventus LLC | 9 | $9,973 |
| Insight Medical Systems, Inc. | 3 | $2,674 |
| Davol Inc. | 2 | $1,121 |
| Zimmer Biomet | 6 | $603 |
| Aesculap Biologics, LLC | 3 | $439 |
| Overture Orthopaedics | 2 | $279 |
| Stryker | 4 | $228 |
| Vericel Corporation | 1 | $105 |
| Johnson & Johnson | 3 | $67 |
| Solventum Corporation | 2 | $48 |
| Spinesmith Holdings, LLC | 2 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$438,080
- ORTHALIGN PLUS$416,949
- ATTUNE$71,928
- PINNACLE$49,147
- ACTIS$49,147
- DJO SURGICAL$40,621
- DJO Surgical TaperFill Hip System$30,701
- DJO Surgical Empowr Knee System$17,923
- MISHA KNEE SYSTEM, SMALL, LEFT$16,200
- OrthAlign Plus System$15,344
- DJO Surgical 3DKnee System$12,728
- DJO Surgical FMP Acetabular System$8,100
- DJO Surgical Exprt Revision Knee$6,848
- HP PARTIAL$5,850
- JII Unicondylar Knee System$3,152
- ARVIS$2,649
- TRUMATCH$1,932
- Journey II XR$446
- NOVOCART 3D$439
- OVERTURETI$260
How this compares
$2,065,419 in reported general payments places this provider in the 95th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 146 | $284 |
| Mupirocin | 37 | $199 |
| Doxycycline Hyclate | 18 | $48 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in la Jolla
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
- Derek AmanatullahStanford$828K
- Nathanael HeckmannLos Angeles$722K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.